Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy
Laura A. Huppert, Michael D. Green, Luke Kim, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 33-45
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Metastatic colorectal cancer: mechanisms and emerging therapeutics
Alice E. Shin, Filippo G. Giancotti, Anil K. Rustgi
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 4, pp. 222-236
Open Access | Times Cited: 256
The Colorectal Cancer Tumor Microenvironment and Its Impact on Liver and Lung Metastasis
Raghav Chandra, John D. Karalis, C. Liu, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6206-6206
Open Access | Times Cited: 107
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 99
Modulating Treg stability to improve cancer immunotherapy
Jee Hye Kang, Roberta Zappasodi
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 911-927
Open Access | Times Cited: 64
Smoking‐Induced M2‐TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5‐Regulated m6A Modification of SOCS2 in NSCLC Cells
Cheng Cheng, Peiwen Wang, Yi Yang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 42
Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
Jing Yang, Bibo Ren, Xuntao Yin, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 32
Regulation of Treg cells by cytokine signaling and co-stimulatory molecules
Yuan Zong, Kaihang Deng, Wai Po Chong
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 30
Exosome-mediated repair of spinal cord injury: a promising therapeutic strategy
Tong Yu, Lili Yang, Ying Zhou, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer
Ke Xu, Hao Wang, Yu‐Xia Zou, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche
Jayanta Mondal, Junfeng Zhang, Qing Feng, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Treg cell-derived exosomes miR-709 attenuates microglia pyroptosis and promotes motor function recovery after spinal cord injury
Wu Xiong, Cong Li, Guang Kong, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy
Dandan Huang, Dafen Xu, Wenxin Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114431-114431
Open Access | Times Cited: 28
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
Lingling Zhu, Xianzhe Yu, Ting Cao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2464-2482
Open Access | Times Cited: 25
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signature
Shenglin Mei, Adele M. Alchahin, Bethel Tesfai Embaie, et al.
JCI Insight (2024)
Open Access | Times Cited: 9
Unleashing the Power of immune Checkpoints: A new strategy for enhancing Treg cells depletion to boost antitumor immunity
Guoxin Li, Siqi Li, Yi Jiang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113952-113952
Open Access | Times Cited: 1
Inflammation in cancer: therapeutic opportunities from new insights
Yifei Xie, Fangfang Liu, Yunfei Wu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Immune response and inflammation in cancer health disparities
Maeve Kiely, Brittany D. Jenkins, Stefan Ambs
Trends in cancer (2021) Vol. 8, Iss. 4, pp. 316-327
Open Access | Times Cited: 42
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 38
MiR‐192‐5p/RB1/NF‐κBp65 signaling axis promotes IL‐10 secretion during gastric cancer EMT to induce Treg cell differentiation in the tumour microenvironment
Jialin Song, Zaihuan Lin, Qing Liu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 8
Open Access | Times Cited: 29
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer
Seyed Esmaeil Ahmadi, Ashkan Shabannezhad, Amir Kahrizi, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 22
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Jiexi Wen, Jie Zeng Yu, Catherine Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2044-2044
Open Access | Times Cited: 7
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma
Jun Ho Ji, Sang Yun Ha, Danbi Lee, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7640-7640
Open Access | Times Cited: 14
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Stéphane Fattori, Aude Le Roy, Jemila Houacine, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3026-3044
Open Access | Times Cited: 14
Aryl hydrocarbon receptor as a drug target in advanced prostate cancer therapy – obstacles and perspectives
Jiřina Procházková, Zuzana Kahounová, Jan Vondráček, et al.
Transcription (2024), pp. 1-20
Closed Access | Times Cited: 5
Foxp3 + Treg-derived IL-10 promotes colorectal cancer-derived lung metastasis
Ahmad Mustafa Shiri, Mohammad Fard-Aghaie, Tanja Bedke, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top